Clinicopathologic and prognostic features of breast cancer in young women: a series from North of Morocco
- PMID: 29121898
- PMCID: PMC5680801
- DOI: 10.1186/s12905-017-0456-1
Clinicopathologic and prognostic features of breast cancer in young women: a series from North of Morocco
Abstract
Background: Literature data reported a higher frequency of breast cancer in young women (BCYW) in developing countries. BCYW is associated with delayed diagnosis, aggressive biology and poor prognosis. However, our knowledge of biological profile, treatment received and outcome of young patients is still limited in Morocco. We propose to analyze clinicopathologic, therapeutic and prognostic features of BCYW among a series of patients native and/or inhabitant of North of Morocco.
Methods: We carried out a retro-prospective study of 331 infiltrating breast cancer cases registered between January 2010 and December 2015. Details of tumor pathology, treatment and outcome were collected. Disease-Free Survival (DFS) and Overall Survival (OS) were assessed by Kaplan-Meier analysis.
Results: A total of 82 patients were diagnosed with breast cancer at the age of 40 or younger (24.8%). Median age was 36 years. More than one quarter (26%) of patients had family history of breast or ovarian cancer. Advanced stages accounted for 34.2% of cases. Median tumor diameter was 2.8 cm. Intermediate and high-grade tumors represented 47.6% and 40.2%, respectively. Nodal involvement was present in 58.5% and lymphovascular invasion was found in 47.7% of the patients. About two thirds (66.2%) of tumors were hormone receptor positive, 29.2% over-expressed HER2 receptor and 23% were triple negative. Patients underwent breast conserving surgery in 38.2% of cases, 61.7% were offered adjuvant chemotherapy and 84.6% received hormone therapy. Five-year DFS and OS were respectively 88.9% and 75.6%. Locoregional recurrence occurred in 2.8% of cases and 8.3% of patients developed distant metastases.
Conclusion: Our findings are in accordance with previous studies that have shown a higher frequency of breast cancer among Moroccan young women. In line with literature data, clinicopathologic profile seems to be aggressive and prognosis is pejorative in our series.
Keywords: Aggressive biology; BRCA1; BRCA2; Breast cancer; Poor prognosis; Survival analysis; Young women.
Conflict of interest statement
Ethics approval and consent to participate
The study was approved by the Ethics Committee for Biomedical Research of the Faculty of Medicine and Pharmacy of Rabat (CERB) registered under number IORG0006594. All participants gave a written informed consent to participate in the study.
Consent for publication
Not applicable for this study.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
Similar articles
-
Triple negative breast cancer in North of Morocco: clinicopathologic and prognostic features.BMC Womens Health. 2016 Oct 22;16(1):68. doi: 10.1186/s12905-016-0346-y. BMC Womens Health. 2016. PMID: 27770782 Free PMC article.
-
Triple negative breast cancer in Moroccan women: clinicopathological and therapeutic study at the National Institute of Oncology.BMC Womens Health. 2012 Oct 7;12:35. doi: 10.1186/1472-6874-12-35. BMC Womens Health. 2012. PMID: 23039971 Free PMC article.
-
Pathological profiles and clinical management challenges of breast cancer emerging in young women in Indonesia: a hospital-based study.BMC Womens Health. 2019 Feb 6;19(1):28. doi: 10.1186/s12905-019-0724-3. BMC Womens Health. 2019. PMID: 30728000 Free PMC article.
-
Overview of resistance to systemic therapy in patients with breast cancer.Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1. Adv Exp Med Biol. 2007. PMID: 17993229 Review.
-
Breast cancer under age 40: a different approach.Curr Treat Options Oncol. 2015 Apr;16(4):16. doi: 10.1007/s11864-015-0334-8. Curr Treat Options Oncol. 2015. PMID: 25796377 Review.
Cited by
-
Clinicopathological characteristics of gene-positive breast cancer in the United Arab Emirates.Breast. 2020 Oct;53:119-124. doi: 10.1016/j.breast.2020.07.005. Epub 2020 Jul 27. Breast. 2020. PMID: 32745951 Free PMC article.
-
Breast Cancer Phenotypes in Africa: A Scoping Review and Meta-Analysis.JCO Glob Oncol. 2023 Sep;9:e2300135. doi: 10.1200/GO.23.00135. JCO Glob Oncol. 2023. PMID: 38085060 Free PMC article.
-
Senescence Marker Protein 30 (SMP30): A Novel Pan-Species Diagnostic Marker for the Histopathological Diagnosis of Breast Cancer in Humans and Animals.Int J Mol Sci. 2021 Feb 26;22(5):2340. doi: 10.3390/ijms22052340. Int J Mol Sci. 2021. PMID: 33652881 Free PMC article.
-
Breast Cancer in Young Women: Is It Different? A Single-Center Retrospective Cohort Study.Clin Med Insights Oncol. 2024 Feb 19;18:11795549241228235. doi: 10.1177/11795549241228235. eCollection 2024. Clin Med Insights Oncol. 2024. PMID: 38380225 Free PMC article.
-
Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC).BMC Cancer. 2020 Aug 10;20(1):747. doi: 10.1186/s12885-020-07250-0. BMC Cancer. 2020. PMID: 32778078 Free PMC article.
References
-
- Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC Cancer Base no. 11. Lyon: International Agency for Research on Cancer; 2013. http://globocan.iarc.fr. Accessed 10 Nov 2016.
-
- Greater Casablanca Cancer Registry: 2005-2007. Edition 2012. http://www.irc.ma/wp-content/uploads/2016/pdf_statistique/registre-des-c.... Accessed 10 Nov 2016.
-
- Znati K, Bennis S, Abbass F, Akasbi Y, Chbani L, Elfatemi H, et al. Breast cancer in young patient in Morocco. Gynecol Obstet Fertil. 2014;42:149–54. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous